Objective: To evaluate the effectiveness of the TheraPoint Focal Pressure Support (TP-FPS) as a non-invasive treatment for pain associated with lateral Epicondylitis (LE). Design: Prospective cohort study. Participants: n = 25 study subjects (20 males and 5 females) ranging in age from 18-65 with pain in one upper limb either dominant (23) or non-dominant (2) associated with lateral epicondylitis for a minimum of six months. Interventions: Study participants were tasked to wear the TP-FPS for 3 hours per day for two weeks except when bathing or during main sleep hours. Outcome measures: Visual analog scale (VAS) pain score pre-and post-treatment period. Results: The combined (male and female) cohort average pre-treatment VAS pain score was 7.44 +/-0.57. Post-treatment VAS pain score was 1.07 +/-0.42, with a total reduction of 6.37 points and reached significance with p=0.0005. Male cohort demonstrated an average pre-treatment VAS pain score of 7.45 +/-0.56. Post-treatment VAS pain score was 1.40 +/-0.45, with a total reduction of 6.05 points and reached significance with p=0.006. Female cohort displayed an average pre-treatment VAS pain score of 7.40 +/-1.92. Post-treatment VAS pain score was 1.70 +/-1.14, with a total reduction of 5.70 and reached significance with p=0.001. No statistically significant difference was observed in the VAS pain score reduction between the male and female groups. Conclusion: The TP-FPS may indeed be a non-invasive therapeutic option for reducing pain associated with lateral epicondylitis.
Introduction
Lateral epicondylitis (LE), otherwise known as tennis elbow, is a common clinical complaint with an incidence of 4-7/1000 patients per year [4, 8, 11] . It is characterized by pain over the lateral humeral epicondyle, and commonly radiates into the dorsal forearm. This condition tends to be self-limiting, often resolving in 6-12 months irrespective of treatment; however, complaints may sometimes last up to two years or longer.
Although an exact cause on how lateral epicondylitis develops has yet to be determined, it is generally agreed that the overuse of wrist and hand functions contributes to the complaint of pain. Tissue-based pathology seen in cases of lateral epicondylitis includes degenerative changes at the proximal common extensor origin. In addition, myofascial trigger points in the muscles attached to the lateral epicondyle may also be a source of pain [6] .
As described by Nirschl et al., workplace activities contribute to 35-64% of all cases [12] . Sports related injury is also a frequent culprit. This places a significant economic burden resulting in a high rate of missed workdays and productivity.
Multiple approaches for the treatment of lateral epicondylitis have been described in the medical literature. Analgesic medications such as oral or topical non-steroidal anti-inflammatory to opioid drugs have been used to treat the pain associated with lateral epicondylitis. In addition, a number of physiotherapeutic approaches including manipulation, therapeutic ultrasound, iontophoresis, phonophoresis, and low-level laser treatment have been described. More invasive interventional methods like corticosteroid, prolotherapy, and regenerative biologic injections have also been described. However, such interventions have not been shown to have consistent long-term clinical benefit [10, 11] .
The aim of this paper is to determine the efficacy of a simple mechanical intervention utilizing the TheraPoint Focal Pressure Support (TP-FPS) in the treatment of pain associated with lateral epicondylitis.
Physiology and Mechanism of Action
The TheraPoint Focal Pressure Support (TP-FPS) provides focal pressure to the area of application. As mentioned prior, there are at least two major theories as to the cause of lateral epicondylitis. This brings to light the unique nature of the TP-FPS. The system is theorized to affect both pathophysiological etiologies of lateral epicondylitis:
1. Active focal pressure for myofascial trigger point [6] and 2. Proximal isometric stabilization of the common extensor tendon, specifically the extensor carpi radialis brevis (ECRB) tendon, to curtail further overuse injury [2, 3, 7, 11] . 
Methods
This was a prospective cohort study that took place over the course of six months.
Participants were recruited throughout the community. The following inclusion criteria was used: males and females between the ages of 18 and 65, pain in one dominant or non-dominant upper limb associated with lateral epicondylitis for a minimum of six months, and have no significant impairment in the use of the affected upper limb.
Exclusion criteria included: potential participants actively receiving physiotherapy for their lateral epicondyle pain, recent (≤6mo) interventional injection, history of surgery to the elbow region, significant functional impairment in the affected upper limb, and/or significant analgesic medication use.
Once participants were deemed eligible they were given a TP-FPS to be used for a two-week treatment period. Participants were trained on donning and doffing the support. They were to wear the support for three hours per day, and not during bathing and main sleep hours.
35 participants were screened and accepted into the study. 30 participants were included in the final analysis with 5 being lost to follow-up. 
Measurements
Primary Outcome: Pre-and post-treatment visual analog scale (VAS) pain measurements were obtained and analyzed.
Statistical Analysis
SPSS Statistics ver. 20.0.1 was used for data analysis. Data was reported as means and standard deviations, medians and ranges. Two-sided, two-sample t-tests were used to compare pre-and post-treatment pain VAS scores with a significance level of 0.05. Cohort was analyzed as a whole. ANOVA was utilized in the Male-to-female group comparison.
Results
30 participants completed the two-week treatment period with the TP-FPS. In the combined (male and female) cohort the average pre-treatment VAS pain score was 7.44 +/-0.57. Post-treatment VAS pain score was 1.07 +/-0.42, with a total reduction of 6.37 points and reached significance with p=0.0005.
Male cohort demonstrated an average pre-treatment VAS pain score of 7.45 +/-0.56. Post-treatment VAS pain score was 1.40 +/-0.45, with a total reduction of 6.05 points and reached significance with p=0.006.
Female cohort displayed an average pre pain score of 7.40 +/-1.92. Post-treatment VAS pain score was 1.70 +/-1.14, with a total reduction of 5.70 and reached significance with p=0.001.
Post-hoc analysis between the male and female group did not show significance between the magnitudes of reduction in their VAS pain scores.
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Discussion
Lateral epicondylitis is a common clinical complaint, affecting 1-3% of the general population each year. A variety of treatments ranging from non physiotherapy techniques to analgesic medication and invasive therapies have been described in the medical literature. Most of these treatments exhibit significant pain reduction in the short term; however, lasting benefits are less clear.
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common clinical complaint, 3% of the general population each year. A variety of treatments ranging from non-invasive physiotherapy techniques to analgesic medication and invasive therapies have been described in the medical these treatments exhibit significant pain reduction in the short term; however, lasting benefits are less The TheraPoint Focal Pressure Support aims to non-invasive treatment approach to with lateral epicondylitis. The t action includes both proximal stabilization of the extensor tendons attaching at the lateral epicondyle specifically the ECRB tendon pressure over the myofascial trigger point. It has been well studied that steadying the improvement in pain by limiting the amount of shear over the lateral epicondyle [18] .
With regards to acupressure, t studies conducted on the effects of pain, with most focusing on low back pain Hsieh, et al. acupressure treatment six times over a one month period was significantly more effective in reducing chronic low back pain compared to a comparison group that was treated with physical therapy ( subsequent study, the Hsieh group significantly reduced chronic low back pain when compared to a placebo acupressure group ( exact mechanism of acupressure has no the dominant rationale is that it stimulates the release of neurochemicals associated with analgesia ( opioid including ß-endorphins, enkephalins, and/or serotonin) [21] . Given that the elbow is also a component of the musculoskeletal system like the spine, it would be reasonable to extrapolate the analgesic effects of acupressure on the elbow.
This study demonstrated that use of the TheraPoint Focal Pressure Support was effective in reducing the VAS pai score of study participants. Post decreased 86%, p=0.0005. No score was observed between Therefore, the TP-FPS may indeed be a viable non therapeutic option for reducing pain associated with lateral epicondylitis.
Limitations of this study include a small sample size and limited power. In addition, the treatment period makes it difficult to determine pain improvement. Participants were for the treatment of their pain. As a result, it is unknown if the TP-FPS has a synergistic effect with other non and invasive treatments. Lastly, our primary outcome was reduction in VAS pain score, which may limited profile of the pain participants. Further studies are needed to evaluate and characterize the effectiveness of non treatments, specifically the TP reduction in lateral epicondylitis.
Conclusion
Lateral epicondylitis, also known as tennis elbow, commonly seen musculoskeletal complaint. multiple approaches in the treatment of lateral epicondylitis. These include but are not limited to analgesic m physiotherapeutic modalities, and invasive interventions. l Pressure Support aims to be a invasive treatment approach to reduce pain associated with lateral epicondylitis. The theorized mechanism of action includes both proximal stabilization of the wrist tendons attaching at the lateral epicondyle, more ECRB tendon, as well as active focal pressure over the myofascial trigger point. It has been well the ECRB tendon lends to improvement in pain by limiting the amount of shear over With regards to acupressure, there are a limited number of studies conducted on the effects of it on musculoskeletal pain, with most focusing on low back pain. According to treatment six times over a one month period was significantly more effective in reducing chronic low back pain compared to a comparison group that ated with physical therapy (n=146) [19] . In a the Hsieh group found that acupressure significantly reduced chronic low back pain when compared to a placebo acupressure group (n=129) [20] . Although the exact mechanism of acupressure has not been established, the dominant rationale is that it stimulates the release of neurochemicals associated with analgesia (i.e. endogenous endorphins, enkephalins, dynorphins, . Given that the elbow is also a nt of the musculoskeletal system like the lumbar reasonable to extrapolate the analgesic effects of acupressure on the elbow.
This study demonstrated that use of the TheraPoint Focal Pressure Support was effective in reducing the VAS pain score of study participants. Post-treatment VAS pain scores No significant difference is pain the male and female groups. FPS may indeed be a viable non-invasive reducing pain associated with lateral Limitations of this study include a small sample size and , the absence of follow-up after the treatment period makes it difficult to determine long-term icipants were to only use the TP-FPS for the treatment of their pain. As a result, it is unknown if a synergistic effect with other non-invasive and invasive treatments. Lastly, our primary outcome was reduction in VAS pain score, which may provide us with a pain experienced by our study participants. Further studies are needed to evaluate and characterize the effectiveness of non-invasive therapeutic treatments, specifically the TP-FPS with regards to pain lateral epicondylitis.
, also known as tennis elbow, is a commonly seen musculoskeletal complaint. There are multiple approaches in the treatment of lateral epicondylitis. These include but are not limited to analgesic medication, physiotherapeutic modalities, and invasive interventions.
This study demonstrated that the TheraPoint Focal Pressure Support may indeed be an effective non-invasive therapeutic option for reducing pain associated with lateral epicondylitis. Further studies are needed to evaluate and characterize the utility of non-invasive therapeutic treatments, specifically the TP-FPS in the treatment of lateral epicondylitis.
